VRTX
Vertex Pharmaceuticals Inc
NASDAQ: VRTX · HEALTHCARE · BIOTECHNOLOGY
$427.38
+0.98% today
Updated 2026-04-29
Market cap
$109.50B
P/E ratio
28.10
P/S ratio
9.12x
EPS (TTM)
$15.32
Dividend yield
—
52W range
$363 – $511
Volume
1.3M
Vertex Pharmaceuticals Inc (VRTX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $216.36M | $199.01M | $175.50M | $102.05M | $143.37M | $1.41B | $1.53B | $1.21B | $580.41M | $1.03B | $1.70B | $2.49B | $3.05B | $4.16B | $6.21B | $7.57B | $8.93B | $9.87B | $11.02B | $12.07B |
| Revenue growth (YoY) | — | -8.0% | -11.8% | -41.9% | +40.5% | +883.9% | +8.3% | -20.6% | -52.1% | +77.9% | +64.9% | +46.2% | +22.5% | +36.6% | +49.1% | +22.1% | +17.9% | +10.5% | +11.7% | +9.6% |
| Cost of revenue | $12.17M | $13.90M | $15.69M | $14.20M | $12.73M | $80.50M | $279.88M | $130.28M | $60.99M | $125.54M | $210.46M | $275.12M | $409.54M | $547.76M | $736.30M | $904.20M | $1.08B | $1.26B | $1.53B | $1.81B |
| Gross profit | $204.19M | $185.11M | $159.82M | $87.85M | $130.64M | $1.33B | $1.25B | $1.08B | $519.43M | $906.79M | $1.49B | $2.21B | $2.64B | $3.62B | $5.47B | $6.67B | $7.85B | $8.61B | $9.49B | $10.27B |
| Gross margin | 94.4% | 93.0% | 91.1% | 86.1% | 91.1% | 94.3% | 81.7% | 89.3% | 89.5% | 87.8% | 87.6% | 88.9% | 86.6% | 86.8% | 88.1% | 88.1% | 87.9% | 87.2% | 86.1% | 85.0% |
| R&D | $371.71M | $513.05M | $516.29M | $550.68M | $637.42M | $707.71M | $806.18M | $918.78M | $855.51M | $996.17M | $1.05B | $1.32B | $1.42B | $1.75B | $1.83B | $3.05B | $2.66B | $3.16B | $3.63B | $3.75B |
| SG&A | $57.86M | $84.73M | $101.91M | $130.19M | $187.80M | $400.72M | $378.20M | $342.74M | $289.21M | $352.58M | $401.43M | $496.08M | $557.62M | $658.50M | $770.46M | $840.10M | $887.20M | $1.14B | $1.46B | $1.75B |
| Operating income | $-229.04M | $-419.79M | $-462.71M | $-613.41M | $-696.08M | $113.82M | $2.33M | $-903.45M | $-692.41M | $-468.66M | $9.94M | $123.24M | $635.15M | $1.20B | $2.86B | $2.78B | $4.31B | $3.83B | $-232.90M | $4.76B |
| Operating margin | -105.9% | -210.9% | -263.6% | -601.1% | -485.5% | 8.1% | 0.2% | -74.5% | -119.3% | -45.4% | 0.6% | 5.0% | 20.8% | 28.8% | 46.0% | 36.7% | 48.2% | 38.8% | -2.1% | 39.4% |
| EBITDA | $-199.52M | $-385.21M | $-426.19M | $-598.88M | $-704.89M | $133.94M | $42.46M | $-554.75M | $-598.75M | $-411.25M | $75.46M | $103.26M | $706.78M | $1.56B | $3.28B | $2.92B | $4.44B | $4.61B | $486.30M | $4.97B |
| EBITDA margin | -92.2% | -193.6% | -242.8% | -586.9% | -491.7% | 9.5% | 2.8% | -45.8% | -103.2% | -39.8% | 4.4% | 4.1% | 23.2% | 37.5% | 52.9% | 38.5% | 49.7% | 46.7% | 4.4% | 41.1% |
| EBIT | $-225.39M | $-412.67M | $-458.38M | $-628.99M | $-735.35M | $98.90M | $4.27M | $-603.12M | $-662.01M | $-473.59M | $14.07M | $41.86M | $634.36M | $1.45B | $3.17B | $2.79B | $4.29B | $4.42B | $280.50M | $4.76B |
| Interest expense | $7.96M | $0.00 | $13.47M | $13.19M | $19.27M | $36.57M | $16.65M | $22.73M | $72.86M | $84.21M | $81.43M | $69.30M | $34.12M | $58.50M | $58.15M | $61.50M | $54.80M | $44.10M | $30.60M | $13.30M |
| Income tax | $-18.50M | $-21.39M | $-30.73M | $19.34M | $19.27M | $19.27M | $38.75M | $-288.57M | $6.96M | $30.38M | $16.66M | $-107.32M | $-1.49B | $218.11M | $405.15M | $388.30M | $910.40M | $760.20M | $784.10M | $690.00M |
| Effective tax rate | 8.2% | 5.2% | 6.3% | -3.1% | -2.6% | 39.4% | -56.8% | 39.3% | -1.0% | -5.8% | -17.5% | -68.7% | -243.7% | 15.6% | 13.0% | 14.2% | 21.5% | 17.4% | 315.5% | 14.9% |
| Net income | $-206.89M | $-391.28M | $-459.85M | $-641.58M | $-754.63M | $29.57M | $-107.03M | $-445.03M | $-738.55M | $-558.12M | $-112.05M | $263.48M | $2.10B | $1.18B | $2.71B | $2.34B | $3.32B | $3.62B | $-535.60M | $3.95B |
| Net income growth (YoY) | — | -89.1% | -17.5% | -39.5% | -17.6% | +103.9% | -461.9% | -315.8% | -66.0% | +24.4% | +79.9% | +335.1% | +695.8% | -43.9% | +130.4% | -13.6% | +41.8% | +9.0% | -114.8% | +838.1% |
| Profit margin | -95.6% | -196.6% | -262.0% | -628.7% | -526.3% | 2.1% | -7.0% | -36.7% | -127.2% | -54.1% | -6.6% | 10.6% | 68.8% | 28.3% | 43.7% | 30.9% | 37.2% | 36.7% | -4.9% | 32.7% |